Improved Quarter for Biotech on Capital Markets ... and Financings ...
Canada NewsWire (press release) - Canada
... gains: Acorda Therapeutics, for example was up 164%. Its shares took off in September after it had announced that its Phase III trial on Fampridine-SR its ...